|
Superiority of Insulin Glargine Lantus vs. NPH: Treat to Normoglycemia Concept.Effect of Insulin Glargine in Comparison to Insulin NPH in Insulin-nave People With Type 2 Diabetes Mellitus Treated With at Least One OAD and Not Adequately Controlled
|
Completed
|
Lantus® / Glimepiride / human insulin [NPH]
|
3
|
LANTU_C_02762
|
King Fahad University Hospital (Al-Khobar), King Abdulaziz University Hospital (Jeddah)
|
|
An Open-Label, Multicenter, Multinational Study of the Safety, Efficacy and Pharmacokinetics of Asfotase Alfa (human recombinant tissue non-specific alkaline phosphatase fusion protein) in Infants and Children ≤ 5 Years of Age with Hypophosphatasia (HPP).
|
Completed
|
Asfotase Alfa
|
2
|
ENB-010-10
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
Efficacy and Safety of Long-Term (6 Months) Innohep® Treatment Versus Anticoagulation With a Vitamin K Antagonist (Warfarin) for the Treatment of Acute Venous Thromboembolism in Cancer Patients
|
Completed
|
Innohep (Tinzaparin) / Warfarin
|
3
|
IN 0901 INT
|
King Abdulaziz Medical City NG (Riyadh), King Fahad Specialist Hospital (Dammam), King Abdulaziz University Hospital (Jeddah), King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
Efficacy and Safety of Irbesartan/Amlodipine Fixed Combination Therapy Compared With Irbesartan Monotherapy in Hypertensive Patients Uncontrolled on Irbesartan 150 mg Monotherapy
|
Completed
|
Irbesartan Amlodipine
|
3
|
IRBAM_R_04219
|
King Abdulaziz Medical City NG (Jeddah)
|
|
Tocilizumab Efficacy and Safety in RA Patients After Inadequate Response to DMARDs or Anti-TNF
|
Completed
|
Tocilizumab
|
3
|
ML22726
|
King Fahad Specialist Hospital (Dammam), King Fahad Medical City (Riyadh), King Abdulaziz University Hospital (Jeddah), Hira Hospital (Makkah)
|
|
Phase IIb Primary Vaccination Study to Evaluate Non-Inferiority & Persistence of the Immune Response of GSK Biologicals' MenACWY Conjugate Vaccine (Intramuscularly) vs Mencevax ACWY (Subcutaneously) to Healthy Subjects (11-55 Years of Age)
|
Completed
|
Meningococcal ACWY Conjugate Vaccine
|
3b
|
107402
|
King Abdulaziz Medical City NG (Riyadh)
|
|
V212-001 A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients With Solid Tumor or Hematologic Malignancy
|
Completed
|
V212
|
3
|
V212-011
|
King Fahad Specialist Hospital (Dammam)
|
|
An Open Label, Randomised Phase III Trial of BIBW 2992 and Vinorelbine Versus Trastuzumab and Vinorelbine in Patients With Metastatic HER2-overexpressing Breast Cancer Failing One Prior Trastuzumab Treatment
|
Completed
|
BIBW 2992 / Vinorelbine / Trastuzumab
|
3
|
1200.75
|
King Fahad Medical City (Riyadh), International Medical Center (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah)
|
|
A Multicenter, Multinational, Extension Study to Evaluate the Long-Term Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)
|
Completed
|
BMN 110
|
3
|
MOR-005
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multinational Clinical Study to Evaluate the Efficacy and Safety of 2.0 mg/kg/Week and 2.0 mg/kg/Every Other Week BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)
|
Completed
|
BMN 110
|
3
|
MOR-004
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
